Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2014
03/19/2014CN103649097A Novel cephalosporins used as antibacterial agents
03/19/2014CN103649094A Crystalline (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine
03/19/2014CN103649093A Substituted imidazopyridines and imidazopyridazines and the use thereof
03/19/2014CN103649091A Substituted 2,3-dihydroimidazo[1,2-c]quinazoline salts
03/19/2014CN103649090A Novel salts of sitagliptin, process for the preparation and pharmaceutical composition thereof
03/19/2014CN103649089A Pyrrolotriazinone derivatives as PI3K inhibitors
03/19/2014CN103649088A 1,6- diazabicyclo [3,2,1] octan- 7 - one derivatives and their use in the treatment of bacterial infections
03/19/2014CN103649087A Substituted imidazopyridines and intermediates thereof
03/19/2014CN103649086A Methods for preparing naphthyridines
03/19/2014CN103649085A Pyridin-2(1h)-one derivatives useful as medicaments for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases
03/19/2014CN103649084A 1,4-disubstituted 1,2,3-triazoles, methods for preparing same, and diagnostic and therapeutic uses thereof
03/19/2014CN103649082A Pyridine derivative and bace-1 inhibitor containing same
03/19/2014CN103649079A Hepatitis C inhibitors and uses thereof
03/19/2014CN103649077A Sulphonamide derivatives of alicyclic amines for the treatment of central nervous system diseases
03/19/2014CN103649076A Pyrrolidinyl urea and pyrrolidinyl thiourea compounds as trka kinase inhibitors
03/19/2014CN103649074A Substituted azaheterocycles for the treatment of cancer
03/19/2014CN103649073A 17alpha-hydroxylase/c17,20-lyase inhibitors
03/19/2014CN103649072A 4h-thieno[3,2-c]chromene-based inhibitors of notum pectinacetylesterase and methods of their use
03/19/2014CN103649066A 5-carbamoyl-adamantan-2-yl amide derivatives, pharmaceutically acceptable salts thereof and preparation process thereof
03/19/2014CN103649062A Piperazine thiazole derivatives useful in the treatment of tauopathies such as alzheimer's disease
03/19/2014CN103649061A Pheno thiazine diaminium salts and their use
03/19/2014CN103649059A 5-membered ring aromatic heterocyclic derivative having NPY Y5 receptor antagonistic activity
03/19/2014CN103649055A Method for manufacturing pyrazole derivative
03/19/2014CN103649053A Aminomethyl quinolone compounds
03/19/2014CN103649048A Indoleamine derivatives for the treatment of central nervous system diseases
03/19/2014CN103649033A Family of aryl, heteroaryl, O-aryl and O-heteroaryl carbasugars
03/19/2014CN103649031A Prenylated hydroxystilbenes
03/19/2014CN103649028A Chrysophaentin analogs that inhibit FtsZ protein
03/19/2014CN103649019A Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia
03/19/2014CN103648588A Compounds for the treatment of cancers associated with human papillomavirus
03/19/2014CN103648531A Method for prevention or treatment of metabolic syndrome
03/19/2014CN103648530A Protein-active agent conjugates and method for preparing the same
03/19/2014CN103648522A Treatment of microbial infections
03/19/2014CN103648521A Intravascular delivery of nanoparticle compositions and uses thereof
03/19/2014CN103648520A Pharmaceutical combination for use in inducing weight loss in diabetes type 2 patients or/and for preventing weight gain in diabetes type 2 patients
03/19/2014CN103648519A Pharmaceutical combination for use in the treatment of diabetes type 2 patients
03/19/2014CN103648506A SUMOylation of SERCA2A and cardiovascular disease
03/19/2014CN103648505A Materials and methods related to microRNA-21, mismatch repair, and colorectal cancer
03/19/2014CN103648504A Oligosaccharides composition for preventing or reducing the risk of metabolic syndrome
03/19/2014CN103648503A Treatment of excessive menstrual bleeding associated with uterine fibroids
03/19/2014CN103648502A Pharmaceutical composition containing oleanolic acid acetate as an active ingredient for preventing or treating TLR- or IL-6-mediated diseases
03/19/2014CN103648501A Induction of immune tolerance by using methotrexate
03/19/2014CN103648500A Methods and use of bifunctional enzyme-building clamp-shaped molecules
03/19/2014CN103648499A Processes for preparing isoquinolinones and solid forms of isoquinolinones
03/19/2014CN103648498A Pharmaceutical combination
03/19/2014CN103648497A Methods and compositions for enhancing fertility and/or inhibiting pregnancy failure and restoring glucose tolerance
03/19/2014CN103648496A Pharmaceutical compositions comprising beta-lactam antibiotic, sulbactam and beta-lactamase inhibitor
03/19/2014CN103648495A Method of treating atherosclerosis in high triglyceride subjects
03/19/2014CN103648494A DHA and EPA in the reduction of oxidative stress
03/19/2014CN103648493A Subcutaneously infusible levodopa prodrug compositions and methods of infusion
03/19/2014CN103648492A Compounds and methods for improving impaired endogenous fibrinolysis using histone deacetylase inhibitors
03/19/2014CN103648491A Methods and pharmaceutical compositions for inhibiting influenza viruses replication
03/19/2014CN103648490A Use of intracellular enzymes for the release of covalently linked bioactives
03/19/2014CN103648489A Multiple antigen presenting immunogenic composition, and methods and uses thereof
03/19/2014CN103648488A Drug combinations and uses in treating a coughing condition
03/19/2014CN103648487A Drug delivery system
03/19/2014CN103648486A Sustained release paracetamol formulations
03/19/2014CN103648485A Pharmaceutical composition of rosuvastatin calcium
03/19/2014CN103648482A Intravaginal delivery system
03/19/2014CN103648307A Edible composition
03/19/2014CN103648306A Serum cholesterol lowering drink and an improved method for lowering cholesterol
03/19/2014CN103648282A Use of thiazolide compounds for the prevention and treatment of viral diseases, cancer and diseases caused by intracellular infections
03/19/2014CN103648279A Treatment of disease with poly-n-acety glucosamine nanofibers
03/19/2014CN103641925A Covalent polycompound of water-soluble polysaccharide and taxane compound, and preparation method and medical application of covalent polycompound
03/19/2014CN103641882A Novel 2,3-dihydroxyl-30-noroleanolic acid as well as preparation method and application thereof in preparing glycosidase inhibitor medicament
03/19/2014CN103641871A Macrocyclic polyphenol compound, and preparation and application thereof in pharmacy
03/19/2014CN103641841A Sesquiterpene lactone compounds as well as preparation method and application thereof
03/19/2014CN103641834A Pyrrolobenzodiazepine compounds, and preparation method and application thereof
03/19/2014CN103641833A Compounds and compositions as protein kinase inhibitors
03/19/2014CN103641829A Triazole derivatives as kinase inhibitors
03/19/2014CN103641828A Triazolonaphthyridine-one derivative compound and preparation method and application thereof
03/19/2014CN103641827A Purrocoline derivative and synthetic method and application thereof
03/19/2014CN103641823A Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme
03/19/2014CN103641822A Canagliflozin compound and pharmaceutical composition thereof
03/19/2014CN103641818A Novel crystal form of tandospirone citrate, preparation method and applications
03/19/2014CN103641817A Novel crystal form of tandospirone citrate, preparation method and applications
03/19/2014CN103641816A Compounds and compositions as protein kinase inhibitors
03/19/2014CN103641814A 4'-O-substituted isoindoline derivatives and compositions comprising and methods of using the same
03/19/2014CN103641807A Extraction method of apigenin, pharmaceutical composition for treating diabetes and application thereof
03/19/2014CN103641794A Sulfonium compounds and their use
03/19/2014CN103641791A Cyclopeptide compound clavatustide B, and preparation method and application thereof
03/19/2014CN103641774A Preparation method of benidipine hydrochloride
03/19/2014CN103641767A Substituted phenylindolyl selenide, selenoxide, selenone and application as tumor cell proliferation inhibitor
03/19/2014CN103641764A Pharmaceutical composition for regulating blood lipid
03/19/2014CN103641762A Transient receptor potential vanilloid 1/epoxidase 2(TRPV1/COX-2) dual inhibitor, and preparation method and application thereof in preparation of analgesic medicament
03/19/2014CN103641713A Preparation method and application of monoglyceride derivative
03/19/2014CN103641712A Hydroxyl acetylated curcumin and application thereof in preparation of ultrasonic sensitive agent for treating atherosclerosis
03/19/2014CN103641688A Mailuoning dihydroanthracene as well as preparation method and use thereof
03/19/2014CN103638563A Biological liquid of biological albumin glue
03/19/2014CN103638535A B ultrasound coupling agent containing traditional Chinese components
03/19/2014CN103638530A Alginic acid-adriamycin amycin bonding medicine and preparation method thereof
03/19/2014CN103638529A Preparation method of medicament for enriching blood
03/19/2014CN103638528A Folic acid targeted nano-particle as well as application and synthesis and detection method thereof
03/19/2014CN103638523A Medicinal composition containing donepezil or its pharmaceutically acceptable salt and beta-receptor blocker
03/19/2014CN103638515A Anti gram-positive bacterium composition of anglerfish skin collagen peptide
03/19/2014CN103638459A Traditional Chinese medicine composition for preventing and treating virus meningitis and preparation method thereof
03/19/2014CN103638432A Traditional Chinese medicine eye drop
03/19/2014CN103638414A Traditional Chinese medicine composition capable of relieving pain
03/19/2014CN103638404A Detoxifying, itching relieving and sterilizing ointment and preparation method thereof
03/19/2014CN103638364A Medicament for treating anaphylaxis skin disease